Last reviewed · How we verify
Plasma-Lyte A — Competitive Intelligence Brief
marketed
Crystalloid fluid replacement solution
Critical Care / Fluid Management
Biologic
Live · refreshed every 30 min
Target snapshot
Plasma-Lyte A (Plasma-Lyte A) — Michael A. Matthay. Plasma-Lyte A is a balanced crystalloid electrolyte solution that replaces fluid and electrolytes lost through dehydration, hemorrhage, or other causes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Plasma-Lyte A TARGET | Plasma-Lyte A | Michael A. Matthay | marketed | Crystalloid fluid replacement solution |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Crystalloid fluid replacement solution class)
- Michael A. Matthay · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Plasma-Lyte A CI watch — RSS
- Plasma-Lyte A CI watch — Atom
- Plasma-Lyte A CI watch — JSON
- Plasma-Lyte A alone — RSS
- Whole Crystalloid fluid replacement solution class — RSS
Cite this brief
Drug Landscape (2026). Plasma-Lyte A — Competitive Intelligence Brief. https://druglandscape.com/ci/plasma-lyte-a. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab